Outcomes of diffuse large b-cell lymphoma with MYC and/or BCL2 protein expression treated with intensive chemotherapy.

被引：0
|
作者：
Issa, Amir
Sathyanarayanan, Vishwanath
Fanale, Michelle A.
Oki, Yasuhiro
Hagemeister, Fredrick B.
Neelapu, Sattva Swarup
Nastoupil, Loretta J.
Fowler, Nathan Hale
Turturro, Francesco
Noorani, Mansoor
Ahmed, Mohamed Amin
Davis, Richard Eric
Rodriguez, Maria Alma
Wang, Michael
Feng, Lei
Young, Ken H.
McDonnell, Timothy
Pinnix, Chelsea Camille
Fayad, Luis
Westin, Jason R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Lymphoma Myeloma, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7563
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
    Johnson, Nathalie A.
    Slack, Graham W.
    Savage, Kerry J.
    Connors, Joseph M.
    Ben-Neriah, Susana
    Rogic, Sanja
    Scott, David W.
    Tan, King L.
    Steidl, Christian
    Sehn, Laurie H.
    Chan, Wing C.
    Iqbal, Javeed
    Meyer, Paul N.
    Lenz, Georg
    Wright, George
    Rimsza, Lisa M.
    Valentino, Carlo
    Brunhoeber, Patrick
    Grogan, Thomas M.
    Braziel, Rita M.
    Cook, James R.
    Tubbs, Raymond R.
    Weisenburger, Dennis D.
    Campo, Elias
    Rosenwald, Andreas
    Ott, German
    Delabie, Jan
    Holcroft, Christina
    Jaffe, Elaine S.
    Staudt, Louis M.
    Gascoyne, Randy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : 3452 - 3459
  • [22] Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy
    Augustyn, A.
    Gunther, J. R.
    Medeiros, L. J.
    Milgrom, S. A.
    Nastoupil, L.
    Neelapu, S. S.
    Nair, R.
    Li, S.
    Ok, C. Y.
    Steiner, R. E.
    Iyer, S. P.
    Ahmed, S.
    Westin, J.
    Rodriguez, M. A.
    Pasalic, D.
    Fayad, L.
    Samaniego, F.
    Dabaja, B.
    Pinnix, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S248 - S248
  • [23] Immunostains for C-MYC and BCL2 Protein Predict Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab
    Perry, A.
    Alvarado-Bernal, Y.
    Laurini, J.
    Smith, L.
    Fu, K.
    Aoun, P.
    Greiner, T.
    Chan, W.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    Vose, J.
    Weisenburger, D.
    LABORATORY INVESTIGATION, 2012, 92 : 361A - 361A
  • [24] Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.
    Morschhauser, Franck
    Jiang, Yanwen
    Jardin, Fabrice
    Herrera, Alex Francisco
    Sehn, Laurie Helen
    Herbaux, Charles
    Flowers, Christopher
    Phillips, Tycel Jovelle
    Guillermo, Armando Lopez
    Diefenbach, Catherine S. Magid
    Gregory, Gareth
    Kim, Austin Injae
    Barbui, Anna Maria
    Balasubramanian, Sandhya
    Harris, Will
    Hirata, Jamie
    Paulson, Joseph N.
    Lee, Calvin
    Lenz, Georg
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy
    Curran, K. M.
    Schaffer, P. A.
    Frank, C. B.
    Lana, S. E.
    Hamil, L. E.
    Burton, J. H.
    Labadie, J.
    Ehrhart, E. J.
    Avery, P. R.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (04) : 1269 - 1279
  • [26] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
    Kramer, MHH
    Hermans, J
    Wijburg, E
    Philippo, K
    Geelen, E
    van Krieken, JHJM
    de Jong, D
    Maartense, E
    Schuuring, E
    Kluin, PM
    BLOOD, 1998, 92 (09) : 3152 - 3162
  • [27] Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
    Kurtz, David M.
    Scherer, Florian
    Newman, Aaron M.
    Craig, Alexander
    Jin, Michael
    Stehr, Henning
    Chabon, Jacob J.
    Esfahani, Mohammad
    Liu, Chih Long
    Zhou, Li
    Glover, Cynthia
    Visser, Brendan C.
    Poultsides, George
    Advani, Ranjana H.
    Maeda, Lauren S.
    Gupta, Neel K.
    Levy, Ronald
    Ohgami, Robert S.
    Davis, R. Eric
    Kunder, Christian A.
    Westin, Jason R.
    Diehn, Maximilian
    Alizadeh, Ash A.
    BLOOD, 2016, 128 (22)
  • [28] Myc rearrangement and concurrent high protein expression of C-Myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma
    Wang, Xingyu
    He, Juan
    He, Hong
    Shuai, Yuhan
    Wang, Lixin
    Li, Yuanxin
    Huang, Ying
    Yu, Kuai
    Zhao, Min
    Xie, Tao
    Li, Dan
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 66
  • [29] High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
    Scott, David W.
    King, Rebecca L.
    Staiger, Annette M.
    Ben-Neriah, Susana
    Jiang, Aixiang
    Horn, Heike
    Mottok, Anja
    Farinha, Pedro
    Slack, Graham W.
    Ennishi, Daisuke
    Schmitz, Norbert
    Pfreundschuh, Michael
    Nowakowski, Grzegorz S.
    Kahl, Brad S.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Ott, German
    Macon, William R.
    Rosenwald, Andreas
    BLOOD, 2018, 131 (18) : 2060 - 2064
  • [30] Prognostic Implications of MYC and BCL2 Expression in Primary Diffuse Large B-cell Lymphoma of the Central Nervous System
    Kim, Sehui
    Nam, Soo Jeong
    Kwon, Dohee
    Kim, Hannah
    Kim, Tae Min
    Heo, Dae Seog
    Park, Sung Hye
    Kim, Chul Woo
    Jeon, Yoon Kyung
    MODERN PATHOLOGY, 2016, 29 : 356A - 356A
12345